MOMENTA PHARMACEUTICALS, INC.

ACTIVE

320 Bent St, 马萨诸塞州米德尔塞克斯县, Massachusetts, United Stateswww.momentapharma.comSubsidiary501–1,000 employeesEstablished: 2001-01-01

Part of 强生

Clinical Trials

25 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2001

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

81.1%

Phase 2

10.8%

Phase 3

5.4%

Trial Status Distribution

Active, not recruiting

67.6%

Completed

24.3%

Terminated

8.1%

Clinical Trials

Trials sponsored by this organization (37)

To further evaluate the efficacy, safety and tolerability of M281 injection for the treatment of patients with Myasthenia gravis, a neuromuscular disease

Phase 1

Active, not recruiting

May 202154 participants

Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia

Phase 1

Active, not recruiting

Jan 2021105 participants

To evaluate the efficacy, safety and tolerability of M281 injection for the treatment of patients with Myasthenia gravis, a neuromuscular disease

Phase 1

Active, not recruiting

Nov 202068 participants

Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia

Phase 1

Active, not recruiting

Sep 201990 participants

Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia

Phase 1

Active, not recruiting

Sep 201990 participants

An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis

Phase 2

Terminated

interventional

Aug 201937 participants

To further evaluate the efficacy, safety and tolerability of M281 injection for the treatment of patients with Myasthenia gravis, a neuromuscular disease

Phase 1

Active, not recruiting

May 201937 participants

To further evaluate the efficacy, safety and tolerability of M281 injection for the treatment of patients with Myasthenia gravis, a neuromuscular disease

Phase 1

Active, not recruiting

Apr 201954 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

Back to Organizations